Burning Rock Biotech (BNR) Income from Continuing Operations (2019 - 2025)

Burning Rock Biotech's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 1949000.0 for Q4 2025.

• In Q4 2025, Income from Continuing Operations rose 79.87% year-over-year to 1949000.0; the TTM figure through Dec 2025 stood at 7300525.36 (up 84.26% YoY), while the FY2025 annual figure was 7803376.48, up 83.57% from the prior year.
• Income from Continuing Operations was 1949000.0 for Q4 2025 at Burning Rock Biotech, up from 2282152.04 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 1273860.7 in Q2 2025 to a low of 41184386.88 in Q1 2022.
• Historically, Income from Continuing Operations has averaged 20659795.82 across 5 years, with a median of 23202000.0 in 2023.
• The sharpest annual moves came in 2021 and 2025: Income from Continuing Operations slumped 247.3% in 2021, then surged 91.43% in 2025.
• A 5-year view of Income from Continuing Operations shows it stood at 39771000.0 in 2021, then grew by 22.56% to 30798000.0 in 2022, then grew by 26.79% to 22546000.0 in 2023, then jumped by 57.06% to 9681000.0 in 2024, then soared by 79.87% to 1949000.0 in 2025.
• The last three Income from Continuing Operations figures came in at 1949000.0 (Q4 2025), 2282152.04 (Q3 2025), and 1273860.7 (Q2 2025), per Business Quant data.